ArticleFrontiers in immunology2020

Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ.

Kirsty E Waddington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.